Stentoft J - Search Results

1

How I treat immune thrombocytopenia - a global view.

Cooper N, Bird R, Chinthammitr Y, George B, Stentoft J, Tomiyama Y, Zaja F, Hokland P. Cooper N, et al. Among authors: stentoft j. Br J Haematol. 2021 Jun;193(6):1076-1086. doi: 10.1111/bjh.17324. Epub 2021 Feb 11. Br J Haematol. 2021. PMID: 33570179 Review. No abstract available.

2

ITP: from idiopathic purpura to immune thrombocytopenia and back.

Stentoft J. Stentoft J. Br J Haematol. 2016 Dec;175(5):755-756. doi: 10.1111/bjh.14414. Epub 2016 Nov 11. Br J Haematol. 2016. PMID: 27861740 Free article. No abstract available.

3

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction.

Stentoft J, Pallisgaard N, Kjeldsen E, Holm MS, Nielsen JL, Hokland P. Stentoft J, et al. Eur J Haematol. 2001 Nov-Dec;67(5-6):302-8. doi: 10.1034/j.1600-0609.2001.00556.x. Eur J Haematol. 2001. PMID: 11872078

4

A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia.

Østergaard M, Stentoft J, Hokland P. Østergaard M, et al. Among authors: stentoft j. Leuk Res. 2004 Nov;28(11):1213-5. doi: 10.1016/j.leukres.2004.03.011. Leuk Res. 2004. PMID: 15380347

5

Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.

Stentoft J, Hokland P, Ostergaard M, Hasle H, Nyvold CG. Stentoft J, et al. Leuk Res. 2006 Apr;30(4):389-95. doi: 10.1016/j.leukres.2005.08.030. Epub 2005 Oct 21. Leuk Res. 2006. PMID: 16243396

6

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B. Larsen OH, et al. Among authors: stentoft j. Br J Haematol. 2013 Jan;160(2):228-36. doi: 10.1111/bjh.12118. Epub 2012 Nov 15. Br J Haematol. 2013. PMID: 23151086 Free article.

7

[Minimal residual disease in malignant diseases of the blood II. Translation and therapeutic consequences].

Hokland P, Ommen HB, Nyvold CG, Stentoft J, Braendstrup K, Andersen BL, Mikkelsen LS, Ostergaard M. Hokland P, et al. Among authors: stentoft j. Ugeskr Laeger. 2009 Jan 19;171(4):232-5. Ugeskr Laeger. 2009. PMID: 19174038 Danish.

8

[Minimal residual disease in malignant diseases of the blood I. Background and pre-clinical validation].

Hokland P, Nyvold CG, Stentoft J, Ommen HB, Ebbesen LH, Braendstrup K, Andersen BL, Mikkelsen LS, Ostergaard M. Hokland P, et al. Among authors: stentoft j. Ugeskr Laeger. 2009 Jan 19;171(4):229-31. Ugeskr Laeger. 2009. PMID: 19174037 Danish.

9

[New treatment options for primary immune thrombocytopenia].

Gudbrandsdottir S, Frederiksen H, Birgens HS, Nielsen CH, Nielsen OJ, Stentoft J, Hasselbalch HC. Gudbrandsdottir S, et al. Among authors: stentoft j. Ugeskr Laeger. 2011 Jan 24;173(4):271-4. Ugeskr Laeger. 2011. PMID: 21262171 Danish.

10

Evaluation of platelet function in thrombocytopenia.

Skipper MT, Rubak P, Stentoft J, Hvas AM, Larsen OH. Skipper MT, et al. Among authors: stentoft j. Platelets. 2018 May;29(3):270-276. doi: 10.1080/09537104.2017.1296566. Epub 2017 Apr 14. Platelets. 2018. PMID: 28409645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page